Incidence of VT greater with third-, than with second-generation OCs

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1298, 2001-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased VTE risk of third-generation OCs not supported

Inpharma, Vol. 1, Iss. 1252, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Third-generation OCs: increased VTE risk supported by new analyses

Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Second-generation kinase inhibitors

By Klebl Bert M Müller Gerhard

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 975-993

Informa Healthcare

Access to resources Recommend Favorite

Cardiotoxicity of Second-Generation Antihistamines

By Roberts D.J.

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 1033-1034

Adis International

Access to resources Recommend Favorite

Newer, second-generation antipsychotics are prescribed for off-label indications far more often than first-generation antipsychotics in ordinary inpatient practice in Italy

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite